Serum adhesion molecule levels as prognostic markers in patients with early systemic sclerosis: A multicentre, prospective, observational study

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Hasegawa, Minoru ^a,b   Asano, Yoshihide ^c   Endo, Hirahito ^d   Fujimoto, Manabu ^b,e   Goto, Daisuke ^e   Ihn, Hironobu ^f   Inoue, Katsumi ^b   Ishikawa, Osamu ^g   Kawaguchi, Yasushi ^h   Kuwana, Masataka ⁱ   Ogawa, Fumihide ^j   Takahashi, Hiroki ^k   Tanaka, Sumiaki ^l   Sato, Shinichi ^c   Takehara, Kazuhiko ^b  

^a UNIVERSITY OF FUKUI   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d TOHO UNIVERSITY   (Japan)

^e UNIVERSITY OF TSUKUBA   (Japan)

^f KUMAMOTO UNIVERSITY   (Japan)

^g GUNMA UNIVERSITY   (Japan)

^h TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

ⁱ KEIO UNIVERSITY   (Japan)

^j NAGASAKI UNIVERSITY   (Japan)

^k SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^l KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; METHOTREXATE; PADGEM PROTEIN; PREDNISOLONE; BIOLOGICAL MARKER; SELECTIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE DISABILITY INDEX; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERSTITIAL LUNG DISEASE; JAPANESE; MAJOR CLINICAL STUDY; MALE; MODIFIED RODNAN TOTAL SKIN THICKNESS SCORE; MULTICENTER STUDY; MULTIPLE REGRESSION; OBSERVATIONAL STUDY; ONSET AGE; PARAMETERS; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SCLERODERMA; SYSTEMIC SCLEROSIS; UNIVARIATE ANALYSIS; VITAL CAPACITY; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; DISEASE COURSE; FOLLOW UP; LONGITUDINAL STUDY; MIDDLE AGED; PATHOLOGY; REGRESSION ANALYSIS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; DISEASE PROGRESSION; E-SELECTIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; LONGITUDINAL STUDIES; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; P-SELECTIN; PROGNOSIS; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; SCLERODERMA, SYSTEMIC; SELECTINS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84895524403     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088150     Document Type: Article

References (56)

1. Gabrielli A, Avvedimento EV, Krieg T (2009) Scleroderma. N Engl J Med 360: 1989-2003.
2. Bhattacharyya S, Wei J, Varga J (2012) Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 8: 42-54.
3. Roumm AD, Whiteside TL, Medsger TA Jr, Rodnan GP (1984) Lymphocytes in the skin of patients with progressive systemic sclerosis. Quantification, subtyping, and clinical correlations. Arthritis Rheum 27: 645-653. (Pubitemid 14089474)
4. Gruschwitz M, Sepp N, Kofler H, Wick G (1991) Expression of class II-MHC antigens in the dermis of patients with progressive systemic sclerosis. Immunobiology 182: 234-255.
5. Springer TA (1994) Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm. Cell 76: 301-314.
6. Tedder TF, Li X, Steeber DA (1999) The selectins and their ligands: adhesion molecules of the vasculature. Adv Mol Cell Biol 28: 65-111.
7. Varki A (1994) Selectin ligands. Proc Natl Acad Sci USA 91: 7390-7397.
8. McEver RP, Cummings RD (1997) Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest 100(11 Suppl): S97-S103. (Pubitemid 28009555)
9. Borges E, Tietz W, Steegmaier M, Moll T, Hallmann R, et al. (1997) P-selectin glycoprotein ligand-1 (PSGL-1) on T helper 1 but not on T helper 2 cells binds to P-selectin and supports migration into inflamed skin. J Exp Med 185: 573-578. (Pubitemid 27078375)
10. Asa D, Raycroft L, Ma L, Aeed PA, Kaytes PS, et al. (1995) The P-selectin glycoprotein ligand functions as a common human leukocyte ligand for P- and E-selectins. J Biol Chem 270: 11662-11670.
11. Dustin ML, Rothlein R, Bhan AK, Dinarello CA, Springer TA (1986) Induction by IL-1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 137: 245-253.
12. Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 43: 2437-2444.
13. Medsger Jr TA (2004) Classification, Purpose. In: Clements PJ, Furst DE, editors. Systemic sclerosis. Philadelphia: Williams & Wilkins p. 17-28.
14. Steen VD (1988) Autoantibodies in systemic sclerosis. Semin Arthritis Rheum 35: 35-42.
15. LeRoy EC, Krieg T, Black C, Medsger TAJ, Fleischmajer R, et al. (1988) Scleroderma (systemic sclerosis): classification, subsets, and pathogenesis. J Rheumatol. 15: 202-205. (Pubitemid 18073738)
16. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Arthritis Rheum 23: 581-590.
17. Clements P, Lachenbrush P, Seibold J, White B, Weiner S, et al. (1995) Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol. 22: 1281-1285.
18. Steen VD, Powell DL, Medsger TAJ (1988) Clinical correlations and prognosis based on serum autoantibodies in patients with systemic sclerosis. Arthritis Rheum 31: 196-203. (Pubitemid 18088039)
19. Kuwana M, Sato S, Kikuchi K, Kawaguchi Y, Fujisaku A, et al. (2003) Evaluation of functional disability using the health assessment questionnaire in Japanese patients with systemic sclerosis. J Rheumatol 30: 1253-1258. (Pubitemid 36666350)
20. Sfikakis PP, Tesar J, Baraf H, Lipnick R, Klipple G (1993) Circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Immunol Immunopathol 68: 88-92. (Pubitemid 23200161)
21. Gruschwitz MS, Hornstein OP, von den Driesch P (1995) Correlation of soluble adhesion molecules in the peripheral blood of scleroderma patients with their in situ expression and with disease activity. Arthritis Rheum 38: 184-189.
22. Ihn H, Sato S, Fujimoto M, Kikuchi K, Kadono T, et al. (1997) Circulating intercellular adhesion molecule-1 in the sera of patients with systemic sclerosis: enhancement by inflammatory cytokines. Br J Rheumatol 36: 1270-1275.
23. Kiener H, Graninger W, Machold K, Aringer M, Graninger WB (1994) Increased levels of circulating intercellular adhesion molecule-1 in patients with systemic sclerosis. Clin Exp Rheumatol. 12: 483-7. (Pubitemid 24323890)
24. Hasegawa M, Sato S. (2008) The roles of chemokines in leukocyte recruitment and fibrosis in systemic sclerosis. Front Biosci13: 3637-3647. (Pubitemid 351594648)
25. Abraham D, Lupoli S, McWhirter A, Plater-Zyberk C, Piela TH, et al. (1991) Expression and function of surface antigens on scleroderma fibroblasts. Arthritis Rheum 34: 1164-1172.
26. Rabquer BJ, Hou Y, Del Galdo F, Kenneth Haines G, 3rd, Gerber ML, et al. (2009) The proadhesive phenotype of systemic sclerosis skin promotes myeloid cell adhesion via ICAM-1 and VCAM-1. Rheumatology (Oxford) 48: 734-740.
27. Hou Y, Rabquer BJ, Gerber ML, Del Galdo F, Jimenez SA, et al. (2010) Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion. Ann Rheum Dis 69: 249-254.
28. Matsushita Y, Hasegawa M, Matsushita T, Fujimoto M, Horikawa M, et al. (2007) Intercellular adhesion molecule-1 deficiency attenuates the development of skin fibrosis in tight-skin mice. J Immunol 179: 698-707. (Pubitemid 46986589)
29. Hamaguchi Y, Nishizawa Y, Yasui M, Hasegawa M, Kaburagi Y, et al. (2002) Intercellular adhesion molecule-1 and L-selectin regulate bleomycin-induced lung fibrosis. Am J Pathol 161:1607-1618. (Pubitemid 35265521)
30. Yoshizaki A, Yanaba K, Iwata Y, Komura K, Ogawa A, et al. (2010) Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol 185: 2502-2515.
31. Pigott R. (1995) Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Commun. 1992;187: 584-589.
32. Rothlein R, Mainolfi EA, Czajkowski M, Marlin SD (1991) A form of circulating ICAM-1 in human serum. J Immunol. 1991;147: 3788-3793.
33. Tsakadze NL, Sithu SD, Sen U, English WR, Murphy G, et al. (2006) Tumor necrosis factor-alpha-converting enzyme (TACE/ADAM-17) mediates the ectodomain cleavage of intercellular adhesion molecule-1 (ICAM-1). J Biol Chem 281: 3157-3164. (Pubitemid 43845925)
34. Tsakadze NL, Sen U, Zhao Z, Sithu SD, English WR, et al. (2004) Signals mediating cleavage of intercellular adhesion molecule-1. Am J Physiology Cell Physiol 287: C55-63. (Pubitemid 38780152)
35. Bohgaki T, Amasaki Y, Nishimura N, Bohgaki M, Yamashita Y, et al. (2005) Up regulated expression of tumour necrosis factor- a converting enzyme in peripheral monocytes of patients with early systemic sclerosis. Ann Rheum Dis 64: 1165-1173. (Pubitemid 41113351)
36. Yang L, Serada S, Fujimoto M, Terao M, Kotobuki Y, et al. (2012) Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One 7: e41994.
37. Ponticos M, Holmes AM, Shi-wen X, Leoni P, Khan K, et al. (2009) Pivotal role of connective tissue growth factor in lung fibrosis: MAPK-dependent transcriptional activation of type I collagen. Arthritis Rheum 60: 2142-2155.
38. Hsu E, Feghali-Bostwick CA (2008) Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways. Am J Pathol 172: 1580-1590. (Pubitemid 351793351)
39. Kusterer K, Bojunga J, Enghofer M, Heidenthal E, Usadel KH, et al. (1998) Soluble ICAM-1 reduces leukocyte adhesion to vascular endothelium in ischemia-reperfusion injury in mice. Am J Physiol 275: G377-80.
40. Rieckmann P, Michel U, Albrecht M, Bruck W, Wockel L, et al. (1995) Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells. J Neuroimmunol 60: 9-15.
41. Gho YS, Kleinman HK, Sosne G (2004) Angiogenic activity of human soluble intercellular adhesion molecule-1. Cancer Res 59: 5128-5132.
42. Otto VI, Gloor SM, Frentzel S, Gilli U, Ammann E, et al. (2002) The production of macrophage inflammatory protein-2 induced by soluble intercellular adhesion molecule-1 in mouse astrocytes is mediated by src tyrosine kinases and p42/44 mitogen-activated protein kinase. J Neurochem 80: 824-834. (Pubitemid 34809235)
43. Schmal H, Czermak BJ, Lentsch AB, Bless NM, Beck-Schimmer B, et al. (1998) Soluble ICAM-1 activates lung macrophages and enhances lung injury. J Immunol 161: 3685-3693.
44. Blann AD, Constans J, Carpentier P, Renard M, Satger B, et al. (2003) Soluble P selectin in systemic sclerosis: relationship with von Willebrand factor, autoantibodies and diffuse or localised/limited disease. Thromb Res 109: 203-206. (Pubitemid 36712909)
45. Sfikakis PP, Charalambopoulos D, Vaiopoulos G, Mavrikakis M (1999) Circulating P- and L-selectin and T-lymphocyte activation and patients with autoimmune rheumatic diseases. Clin Rheumatol 18: 28-32. (Pubitemid 29104749)
46. Ates A, Kinikli G, Turgay M, Duman M (2004) Serum-soluble selectin levels in patients with rheumatoid arthritis and systemic sclerosis. Scand J Immunol 59: 315-320. (Pubitemid 38429299)
47. Hasegawa M, Asano Y, Endo H, Fujimoto M, Goto D, et al. (2012) Serum chemokine levels as prognostic markers in patients with early systemic sclerosis: a multicenter, prospective, observational study. Mod Rheumatol 23: 1076-1084.
48. Horikawa M, Fujimoto M, Hasegawa M, Matsushita T, Hamaguchi Y, et al. (2006) E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. Am J Pathol 169: 740-749. (Pubitemid 44411942)
49. Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W (1993) Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus. J Rheumatol 20: 809-814. (Pubitemid 23158474)
50. Ihn H, Sato S, Fujimoto M, Takehara K, Tamaki K (1998) Increased serum levels of soluble vascular cell adhesion molecule-1 and E-selectin in patients with systemic sclerosis. Br J Rheumatol 37: 1188-1192.
51. Andersen GN, Caidahl K, Kazzam E, Petersson AS, Waldenstrom A, et al. (2000) Correlation between increased nitric oxide production and markers of endothelial activation in systemic sclerosis: findings with the soluble adhesion molecules E-selectin, intercellular adhesion molecule 1, and vascular cell adhesion molecule 1. Arthritis Rheum 43: 1085-1093. (Pubitemid 30368189)
52. Blann AD, Sanders PA, Herrick A, Jayson MIV (1996) Soluble L-selectin in the connective tissue diseases. Br J Haematol 95: 192-194. (Pubitemid 26340250)
53. Dunne JV, van Eeden SF, Keen KJ (2012) L-selectin and skin damage in systemic sclerosis. PLoS One 7: e44814.
54. Shimada Y, Hasegawa M, Takehara K, Sato S. Elevated serum L-selectin levels and decreased L-selectin expression on CD8 (+) lymphocytes in systemic sclerosis. Clin Exp Immunol. 2001; 124(3): 474-479. (Pubitemid 32701711)
55. Musial K, Zwolinska D, Polak-Jonkisz D, Berny U, Szprynger K, et al. (2005) Serum VCAM-1, ICAM-1, and L-selectin levels in children and young adults with chronic renal failure. Pediatr Nephrol. 20: 52-5. (Pubitemid 40057854)
56. Haught WH, Mansour M, Rothlein R, Kishimoto TK, Mainolfi EA, et al. (1996) Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease. Am Heart J 132: 1-8. (Pubitemid 26243685)